We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Healsun Biopharm Stock

Invest in or calculate the value of your shares in Healsun Biopharm or other pre-IPO companies through EquityZen's platform.

Get Started

Healsun Biopharm Stock (HEAB)

Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO

About Healsun Biopharm Stock

Founded

2015

Industries

Messaging and Telecommunications, Sports, Content and Publishing

Healsun Biopharm is a high-tech antibody/recombinant protein CRO/CDMO company, offering end-to-end service by multiple platforms from early developability assessments, stable cell line construction, culture medium customization, process development (including ADC), to pilot production, IND application and clinical production.

Healsun Biopharm Press Mentions

Stay in the know about the latest news on Healsun Biopharm

HealSun Biopharm on LinkedIn: #pegsummit

linkedin • May 24, 2024

Healsun Biopharm Management

Leadership team at Healsun Biopharm

Founder

Yuliang Huang

CEO

Haoqiang Li

Locked Features

Join now and verify your accreditation status to gain access to:

  • Healsun Biopharm Current Valuation
  • Healsun Biopharm Stock Price
  • Healsun Biopharm Management
  • Available deals in Healsun Biopharm and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Healsun Biopharm Cap Table and Funding History by Share Class and Liquidity Preferences
    • Healsun Biopharm Revenue and Financials
    • Healsun Biopharm Highlights
    • Healsun Biopharm Business Model
    • Healsun Biopharm Risk Factors
  • Healsun Biopharm Research Report from SACRA Research
Join Now

Trading Healsun Biopharm Stock

How to invest in Healsun Biopharm stock?

Accredited investors can buy pre-IPO stock in companies like Healsun Biopharm through EquityZen funds. These investments are made available by existing Healsun Biopharm shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Healsun Biopharm stock?

Shareholders can sell their Healsun Biopharm stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."